ViaLongeVita

From the Czech desk of MedScopeGlobal. Shared with attribution — the local desk added context for this edition.

[Comment] Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumoursVIP

Treatment sequencing in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs) remains a major unmet clinical need.1 Although somatostatin receptor-positive, well differentiated GEP-NETs often follow a somewhat indolent course, disease progression eventually requires treatment decisions that balance tumour c

Este conteúdo não é diagnóstico médico nem recomendação de tratamento. Consulte sempre o seu médico ou o SUS.